Anthera Pharmaceuticals Launches With Significant Series A Funding

Anthera Pharmaceuticals, a private start-up pharmaceutical company specializing in serious respiratory and inflammatory diseases, announced it has completed its Series A Preferred financing and is moving forward under a proven leadership team. The new company will be lead by Paul Truex in the role of president and chief executive officer, who has extensive experience building successful companies, most recently Peninsula Pharmaceuticals.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19773620&full=1)